204 related articles for article (PubMed ID: 18240599)
1. [New drug therapy for retinal degeneration].
Ohguro H
Nippon Ganka Gakkai Zasshi; 2008 Jan; 112(1):7-21. PubMed ID: 18240599
[TBL] [Abstract][Full Text] [Related]
2. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory peptide of mitochondrial μ-calpain protects against photoreceptor degeneration in rhodopsin transgenic S334ter and P23H rats.
Ozaki T; Ishiguro S; Hirano S; Baba A; Yamashita T; Tomita H; Nakazawa M
PLoS One; 2013; 8(8):e71650. PubMed ID: 23951212
[TBL] [Abstract][Full Text] [Related]
4. Preservation of retinal morphology and functions in royal college surgeons rat by nilvadipine, a Ca(2+) antagonist.
Yamazaki H; Ohguro H; Maeda T; Maruyama I; Takano Y; Metoki T; Nakazawa M; Sawada H; Dezawa M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):919-26. PubMed ID: 11923229
[TBL] [Abstract][Full Text] [Related]
5. Retinal cAMP levels during the progression of retinal degeneration in rhodopsin P23H and S334ter transgenic rats.
Traverso V; Bush RA; Sieving PA; Deretic D
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1655-61. PubMed ID: 11980887
[TBL] [Abstract][Full Text] [Related]
6. Study of pharmacological effects of nilvadipine on RCS rat retinal degeneration by microarray analysis.
Sato M; Ohguro H; Ohguro I; Mamiya K; Takano Y; Yamazaki H; Metoki T; Miyagawa Y; Ishikawa F; Nakazawa M
Biochem Biophys Res Commun; 2003 Jul; 306(4):826-31. PubMed ID: 12821116
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of nilvadipine delays photoreceptor degeneration of heterozygous retinal degeneration slow (rds) mouse.
Takeuchi K; Nakazawa M; Mizukoshi S
Exp Eye Res; 2008 Jan; 86(1):60-9. PubMed ID: 17976582
[TBL] [Abstract][Full Text] [Related]
8. Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic
Vent-Schmidt RYJ; Wen RH; Zong Z; Chiu CN; Tam BM; May CG; Moritz OL
J Neurosci; 2017 Jan; 37(4):1039-1054. PubMed ID: 28490005
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa.
Pearce-Kelling SE; Aleman TS; Nickle A; Laties AM; Aguirre GD; Jacobson SG; Acland GM
Mol Vis; 2001 Feb; 7():42-7. PubMed ID: 11239245
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration.
LaVail MM; Nishikawa S; Steinberg RH; Naash MI; Duncan JL; Trautmann N; Matthes MT; Yasumura D; Lau-Villacorta C; Chen J; Peterson WM; Yang H; Flannery JG
Exp Eye Res; 2018 Feb; 167():56-90. PubMed ID: 29122605
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa.
Tam BM; Moritz OL
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3234-41. PubMed ID: 16877386
[TBL] [Abstract][Full Text] [Related]
12. Dark rearing rescues P23H rhodopsin-induced retinal degeneration in a transgenic Xenopus laevis model of retinitis pigmentosa: a chromophore-dependent mechanism characterized by production of N-terminally truncated mutant rhodopsin.
Tam BM; Moritz OL
J Neurosci; 2007 Aug; 27(34):9043-53. PubMed ID: 17715341
[TBL] [Abstract][Full Text] [Related]
13. Cell Death Pathways in Mutant Rhodopsin Rat Models Identifies Genotype-Specific Targets Controlling Retinal Degeneration.
Viringipurampeer IA; Gregory-Evans CY; Metcalfe AL; Bashar E; Moritz OL; Gregory-Evans K
Mol Neurobiol; 2019 Mar; 56(3):1637-1652. PubMed ID: 29911255
[TBL] [Abstract][Full Text] [Related]
14. Low expression of rhodopsin kinase in pineal gland in Royal College of Surgeons rat.
Takano Y; Ohguro H; Ohguro I; Yamazaki H; Mamiya K; Ishikawa F; Nakazawa M
Curr Eye Res; 2003 Aug; 27(2):95-102. PubMed ID: 14632161
[TBL] [Abstract][Full Text] [Related]
15. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse.
Takano Y; Ohguro H; Dezawa M; Ishikawa H; Yamazaki H; Ohguro I; Mamiya K; Metoki T; Ishikawa F; Nakazawa M
Biochem Biophys Res Commun; 2004 Jan; 313(4):1015-22. PubMed ID: 14706644
[TBL] [Abstract][Full Text] [Related]
16. Prolonged rhodopsin phosphorylation in light-induced retinal degeneration in rat models.
Ishikawa F; Ohguro H; Ohguro I; Yamazaki H; Mamiya K; Metoki T; Ito T; Yokoi Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5204-11. PubMed ID: 17122104
[TBL] [Abstract][Full Text] [Related]
17. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse.
Frasson M; Sahel JA; Fabre M; Simonutti M; Dreyfus H; Picaud S
Nat Med; 1999 Oct; 5(10):1183-7. PubMed ID: 10502823
[TBL] [Abstract][Full Text] [Related]
18. A diffusible factor from normal retinal cells promotes rod photoreceptor survival in an in vitro model of retinitis pigmentosa.
Streichert LC; Birnbach CD; Reh TA
J Neurobiol; 1999 Jun; 39(4):475-90. PubMed ID: 10380070
[TBL] [Abstract][Full Text] [Related]
19. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(-/-) mouse.
Campbell M; Humphries M; Kennan A; Kenna P; Humphries P; Brankin B
Exp Eye Res; 2006 Sep; 83(3):484-92. PubMed ID: 16643895
[TBL] [Abstract][Full Text] [Related]
20. Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa.
Guerin K; Gregory-Evans CY; Hodges MD; Moosajee M; Mackay DS; Gregory-Evans K; Flannery JG
Exp Eye Res; 2008 Sep; 87(3):197-207. PubMed ID: 18644591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
